The Challenges with Traditional TFF

Tangential flow filtration (TFF) relies on recirculation to control membrane fouling, but most TFF systems were designed for large volumes. As R&D shifts toward smaller, higher-value batches, traditional systems become inefficient, wasteful, and difficult to automate.

  • Minimum Volume Mismatch — Existing systems require 5–10 mL minimum working volumes, wasting material when only sub-mL samples are needed.
  • Manual Operation — Most benchtop systems require manual control and close monitoring when processing low-volume samples, making automation impractical.
  • Scale-Up Discontinuity — R&D may be forced to use alternative purification methods, and the results often don't transfer to production, requiring additional process development at larger scales.

Our First-Principles Design Approach

Tanda systems are designed from first principles to eliminate unnecessary volume, complexity, and operator dependence.

  • Minimized Hold-Up Volume — Absolute minimum tubing paths reduce sample loss and batch size.
  • Small Format Filters — Small hollow fiber filters with a minimum filtration surface area of 4 cm² or less reduce tubing length and hold-up volume.
  • Passive Pressure Control — Application-driven flow path design eliminates the need for pressure sensors and back-pressure valves.
  • Automated Process Termination — Weight-based permeate monitoring stops the process automatically — no manual intervention required.

The Results

Lower cost: Routine processing of sub-mL samples preserves valuable or hazardous materials.

Higher throughput: Minimal training, fast setup, and small footprint enable parallel processing.

Straightforward tech transfer: Consistent filter formats and well-understood laminar flow simplify scale-up.

How We Compare

Capability Tanda Systems Others
Minimum Working Volume <0.5 mL 5–10 mL
Hold-Up Volume <0.5 mL 5–15 mL typical
Pressure Control Passive pressure control Pinch valve with manual or P&ID
Setup Time 5 minutes (ReadyPath™) 30–60 minutes
Automation Level Walk-away operation Manual or automated
Scalability Directly scalable filter design May need different filter technologies for sub-mL sample volumes
Alternative to Dialysis Faster and easier alternative to dialysis Faster but much more complicated than dialysis

Selected Applications

  • LNP & RNA Therapeutics — Buffer exchange and concentration for mRNA and siRNA formulations. Low hold-up volume is critical when working with expensive nucleic acid payloads.
  • Exosomes & EVs — Gentle isolation and purification at research-relevant volumes. Our low-shear flow paths preserve vesicle integrity during processing.
  • Proteins & Biologics — Concentration, diafiltration, and formulation. TxFlow™ Go handles 0.5–500 mL; custom systems scale to production volumes.
  • Nanoparticles — Purification and concentration of nanoparticles after reaction.
  • Faster Alternative to Dialysis — Complete buffer exchange in 30 minutes to a few hours instead of days, while reducing buffer consumption by >95% through automated diafiltration.

Questions about your application? Talk to an engineer or email support@mtwbiotech.com